Bharat Biotech's Covaxin granted emergency use approval for kids aged 2-18 years

  • 3 years ago
The Subject Expert Committee on Covid-19 has granted emergency use approval to Bharat Biotech's Covaxin for children in the 2-18 years age group.

Recommended